This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Harmonigenic Corporation, University of Rochester. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Innovations of Bradley Turner in Cancer Treatment
Introduction
Bradley Turner is an accomplished inventor based in Rochester, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. His work focuses on utilizing light scattering technology to enhance the efficacy of chemotherapy.
Latest Patents
Turner's most notable patent is titled "Methods and systems for treating cancer based on response prediction using light scattering technology." This patent discloses methods and systems that employ light scattering techniques, such as a multiphoton laser-scanning microscope. The technology quantifies the scattering directionality of second harmonic generation (SHG) from biopsy samples of cancer, which aids in predicting the effectiveness of neoadjuvant chemotherapy. This innovative approach has the potential to improve treatment outcomes for cancer patients.
Career Highlights
Throughout his career, Bradley Turner has worked with prestigious institutions, including the University of Rochester and Harmonigenic Corporation. His experience in these organizations has allowed him to develop and refine his groundbreaking technologies in cancer treatment.
Collaborations
Turner has collaborated with notable colleagues, including Robert Lawrence Hill and David Hicks. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Bradley Turner's innovative work in cancer treatment exemplifies the impact of technology on healthcare. His patented methods and systems represent a significant advancement in predicting chemotherapy efficacy, showcasing the potential for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile